Perspective Therapeutics, Inc. (CATX): Total Assets
$266.97M
As of 2025-12-31
$392.02M
As of 2026-06-30
+66.3%
3-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $266.97M | -21.7% | 2026-03-16, Balance as of period end |
| 2024-12-31 | $341.10M | +248.4% | 2026-03-16, Balance as of period end |
| 2023-12-31 | $97.89M | +68.5% | 2025-03-28, Balance as of period end |
| 2022-12-31 | $58.09M | n/a | 2024-03-28, Balance as of period end |
| 2022-06-30 | $64.44M | -8.5% | 2022-09-28, Balance as of period end |
| 2021-06-30 | $70.42M | +709.5% | 2022-09-28, Balance as of period end |
| 2020-06-30 | $8.70M | -7.7% | 2021-09-27, Balance as of period end |
| 2019-06-30 | $9.42M | +26.4% | 2020-09-25, Balance as of period end |
| 2018-06-30 | $7.46M | -39.2% | 2019-09-27, Balance as of period end |
| 2017-06-30 | $12.27M | -32.2% | 2018-09-26, Balance as of period end |
| 2016-06-30 | $18.10M | -21.3% | 2017-09-28, Balance as of period end |
| 2015-06-30 | $23.00M | -13.4% | 2016-09-09, Balance as of period end |
| 2014-06-30 | $26.55M | +276.3% | 2015-09-14, Balance as of period end |
| 2013-06-30 | $7.06M | -6.0% | 2014-09-29, Balance as of period end |
| 2012-06-30 | $7.51M | -4.9% | 2013-09-30, Balance as of period end |
| 2011-06-30 | $7.89M | n/a | 2012-10-26, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Perspective Therapeutics, Inc. (CATX) | 2025-12-31 | $266.97M | -21.7% |
| Arcturus Therapeutics Holdings Inc. (ARCT) | 2025-12-31 | $271.15M | -21.2% |
| Nature's Sunshine Products Inc (NATR) | 2025-12-31 | $261.15M | +8.4% |
| Damora Therapeutics, Inc. (DMRA) | 2025-12-31 | $260.53M | n/m |
| Phathom Pharmaceuticals, Inc. (PHAT) | 2025-12-31 | $259.15M | -31.5% |
| Contineum Therapeutics, Inc. (CTNM) | 2025-12-31 | $276.64M | +30.0% |
| Assembly Biosciences, Inc. (ASMB) | 2025-12-31 | $257.59M | +116.2% |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 2025-12-31 | $277.17M | +70.2% |
| Macrogenics Inc (MGNX) | 2025-12-31 | $256.85M | -1.8% |
Compare CATX, ARCT, NATR, DMRA side by side · Screen every company in Pharmaceutical Preparations ↗